Results 161 to 170 of about 371,827 (350)
Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
What's New? Thin cutaneous malignant melanoma has an excellent ten‐year melanoma‐specific survival of 93%–97%. Moreover, the incidence of melanoma is higher among individuals with high socioeconomic status, which may protect them from other diseases. This nationwide matched cohort study found that patients with thin cutaneous malignant melanoma have a ...
Ylva Naeser +4 more
wiley +1 more source
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
Andrew L. Feldman +14 more
openalex +1 more source
Extracellular vesicle‐based vaccines and immunotherapeutics for treatment of cancer
This review highlights the innovative value of extracellular vesicles (EVs) as cancer vaccines and immunotherapy carriers. EVs have natural advantages such as low immunogenicity, high biocompatibility, stability, and precise targeting, enabling efficient delivery of tumor antigens (e.g., HER2, AFP) and immune stimulants (e.g., TLR ligands, cytokines ...
Lejia Tan +4 more
wiley +1 more source
Peripheral T-Cell Lymphoma: What's Next? [PDF]
Yoon SE, Kim WS.
europepmc +1 more source
Lymph‐based liquid biopsy: Current progress and future potential
Recent evidence under the revised Starling principle indicates that lymph‐based liquid biopsies may offer superior diagnostic performance over blood‐based counterparts in certain clinical scenarios, such as early‐stage solid tumor detection. Currently, various biomarkers within the lymphatic system show significant diagnostic potential for a range of ...
Dongdong Liu +6 more
wiley +1 more source
Primary Cutaneous Peripheral T-Cell Lymphoma With Follicular Helper T-Cell Phenotype. [PDF]
Planella-Fontanillas N +9 more
europepmc +1 more source

